Hello all,
Greetings from Cold Spring Harbor! The Geuvadis RNAseq poster was really
popular and lots of people were impressed by the dataset and the
analyses that we put together for the poster. There is definitely a lot
of interest in the paper and the dataset.
Now that there are so many people waiting for the paper and the data to
come out, let's keep on working to make sure we'll get it done sooner
rather than later. A couple of questions/issues:
- FYI to everyone, the GEM manuscript is still not submitted despite
many promises to get it done by the end of April.
- Micha/Thasso, what's the situation regarding the gem-bam conversions?
Are you running them and if not, can you start asap? We need to make
sure that if the manuscript gets submitted and we can decide to use GEM
(I wish that this was a question of when and not if), there's no delay
from this.
- genotype data of the Phase2 samples: I talked with Bryan Howie
(developer of IMPUTE2), and he said that including rare variants and
indels in the reference panel should be fine. Natalja/Thomas, am I
correct that we already had chr1 results where imputation was done with
the full Phase2 set + the total Phase1 without any additional variant
filters, and this looked pretty good? On another note, I learned that
the Phase2 genotype calls are almost there - I'm discussing with people
from the Broad if we could use them and if that would give us better
data than imputing.
cheers,
Tuuli
--
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen(a)unige.ch